Skip to main content


Restart of production in separation plant SP5

23 October 2015

Today Urenco Nederland has restarted production capacity that was paused as a result of the incident that took place on 27 August 2015. The investigation into the technical cause of the incident has been concluded and reported to the Authority for Nuclear Safety and Radiation Protection (ANVS). This investigation was conducted by Urenco, under supervision of the ANVS and with input from independent bodies. It has been concluded that the incident was caused by a chemical reaction as a result of a build-up of fluorine in a filter with trapping material. Measures have been implemented in all Urenco’s enrichment plants to prevent reoccurrence. The ANVS has approved restart of production, having taken three aspects into consideration: the investigation into the cause of the incident, the manner in which the consequences have been addressed and the procedure for restarting production. As part of our focus on continual improvement, we will maintain our review of processes and operations on all our sites.


About Urenco

Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.

With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.

Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.


Sign up to our newsletter by entering your email address below.

Back to
the goals